Professor CATRIN RUTLAND CATRIN.RUTLAND@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR MEDICINE
Heterochromatin modulation and PCG control of gene expression mediated by noncoding RNA in cancer
Rutland, Catrin S.; de Brot, Simone; James, Victoria; Mongan, Nigel P.
Authors
Simone de Brot
Professor VICTORIA JAMES VICTORIA.JAMES@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR BIOLOGY
Professor Nigel Mongan nigel.mongan@nottingham.ac.uk
ASSOCIATE PRO-VICE CHANCELLORGLOBAL ENGAGEMENT
Contributors
Jayprokas Chakrabarti
Editor
Sanga Mitra
Editor
Abstract
In eukaryotes, the packaging of DNA and proteins, termed chromatin, is an essential determinant of transcription. The basic unit of chromatin, the nucleosome, is composed of ∼146 base pairs of DNA spooled around a dense protein core containing two copies each of histones H2A, H2B, H3, and H4. These histone proteins are highly conserved and possess tails, which extend and interact with DNA. Covalent modifications that alter the charge of the histone tail are believed to influence their electrostatic interaction with DNA and act as interaction surfaces for epigenetic effectors that influence the level of chromatin compaction and accessibility to the transcriptional apparatus. Less-compacted chromosomal regions, euchromatin, tend to be gene rich and transcriptionally active. In contrast, condensed constitutive heterochromatin plays an essential function in chromosomal integrity and structural regions such as the centromere and telomere. Facultative heterochromatin plays an essential role by imposing the differentiation-specific transcriptional regulation required to underpin cellular identity. Long noncoding RNAs (lncRNAs) are emerging as key transcriptional regulators, which cooperate with the polycomb repressive complexes and the heterochromatin apparatus in differentiation. Unsurprisingly, disruption of this key pathway is now recognized to play important roles in carcinogenesis and metastases. In this chapter, we review current understanding of the normal and oncogenic functions of lncRNAs, polycomb, and heterochromatin.
Citation
Rutland, C. S., de Brot, S., James, V., & Mongan, N. P. (2018). Heterochromatin modulation and PCG control of gene expression mediated by noncoding RNA in cancer. In J. Chakrabarti, & S. Mitra (Eds.), Cancer and Noncoding RNAs (359-372). Elsevier. https://doi.org/10.1016/b978-0-12-811022-5.00019-x
Online Publication Date | Oct 13, 2017 |
---|---|
Publication Date | Jul 18, 2018 |
Deposit Date | Dec 7, 2018 |
Publisher | Elsevier |
Pages | 359-372 |
Series Title | Translational Epigenetics |
Series Number | 1 |
Book Title | Cancer and Noncoding RNAs |
Chapter Number | 19 |
ISBN | 9780128110225 |
DOI | https://doi.org/10.1016/b978-0-12-811022-5.00019-x |
Public URL | https://nottingham-repository.worktribe.com/output/1387988 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/B978012811022500019X |
Contract Date | Mar 15, 2017 |
You might also like
The Role of Extracellular Vesicles in Allergic Sensitization: A Systematic Review
(2024)
Journal Article
SnoRNAs in cardiovascular development, function, and disease
(2024)
Journal Article
PBMC-derived extracellular vesicles in a smoking-related inflammatory disease model
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search